Immunotherapy (PD-1/PD-L1 inhibitor) in combination with chemotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Immunotherapy (PD-1/PD-L1 inhibitor) in combination with chemotherapy, covering 2026-04-23 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO]) [Phase 3]